"Město Havlíčkův Brod leží v pahorkaté oblasti kraje Vysočina. Historie nemocnice v Havlíčkově Brodě se píše od roku 1897. Dnes má své významné místo v Kraji Vysočina a v poskytování svých služeb má nadregionální charakter. Nemocnice má vytvořeny dobré podmínky pro lékařskou i ošetřovatelskou péči o nemocné a splňuje požadavky, které jsou kladeny na zdravotnické zařízení 21. století. Nemocnice disponuje 534 lůžky na 19 odděleních. Velmi dobré zázemí pro diagnostiku a výsledky v léčbě nemocných posunuly havlíčkobrodskou nemocnici na evropskou úroveň."

During the past decade, Nemocnice Havlickuv Brod p.o. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nemocnice Havlickuv Brod p.o." #1 sponsor was "Ferring Pharmaceuticals" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Cardior Pharmaceuticals GmbH" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Integra LifeSciences Services" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nemocnice Havlickuv Brod p.o." #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Nemocnice Havlickuv Brod p.o." are "Atrial Fibrillation" (1 trials), "Bowel Cleanliness" (1 trials), "Dyslipidemia" (1 trials), "Hallux Limitus" (1 trials) and "Hallux Rigidus" (1 trials). Many other conditions were trialed in "Nemocnice Havlickuv Brod p.o." in a lesser frequency.

Most popular intervention types in "Nemocnice Havlickuv Brod p.o." are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "CDR132L" (1 trials), "Edoxaban" (1 trials), "Empagliflozin" (1 trials) and "K-877" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnice Havlickuv Brod p.o." are 8 trials for "All" genders.

Currently, there are NaN active trials in "Nemocnice Havlickuv Brod p.o.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Nemocnice Havlickuv Brod p.o., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnice Havlickuv Brod p.o., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".